Email Updates

You are here

AVAC's Blog: P-Values

  • At AVAC, we are seeing remarkable new developments and opportunities to engage in HIV and COVID research, development and advocacy. Here is a round-up of what’s been happening, essential reading and resources to help in your advocacy efforts, and some upcoming webinars to join.

    March 25, 2022
    AVAC
  • These eight advocates will participate in an 18-month program that supports their advocacy efforts, invests in the development of their skills, shapes the agenda for HIV prevention research, and influences how quickly new interventions move into policy and programs.

    March 14, 2022
    General
    AVAC
  • AVAC is tremendously proud of its 2020/2021 class of Fellows whose tenure in the program began during a time of great uncertainty in HIV prevention and in global health. Their tenacity, passion and unwavering commitment are central tenants to recalibrating global health equity.

    March 11, 2022
    General
    AVAC
  • AVAC enthusiastically welcomes the South African Health Products Regulatory Authority’s (SAHPRA) approval of the monthly Dapivirine Vaginal Ring for use by women ages 18 and older to reduce their HIV risk.

    March 11, 2022
    AVAC
  • AVAC and our partners have been busy the first couple of months of 2022. Here is a round-up of essential reading and new and updated resources including HIV treatment studies, PrEP, stakeholder engagement, research fundamentals and more.

    March 7, 2022
    AVAC
  • CROI concluded with dynamic sessions that put a spotlight on where and how HIV prevention must do better. It’s no surprise to many advocates that the answers involve a commitment to informed choice, comprehensive & integrated responses and community-led interventions.

    March 3, 2022
    AVAC
  • Welcome to Virtual CROI week two! Here’s a roundup of the exciting science heard last week across the spectrum of HIV prevention, and on cure research (more on this further down) with a groundbreaking new case of HIV remission.

    February 22, 2022
    AVAC
  • This year's annual Conference on Retroviruses and Opportunistic Infections (CROI), February 12-24, begins this weekend and will once again, be virtual! This forum offers the latest from research on HIV, tuberculosis (TB) and hepatitis (HEP) and now also features findings from COVID-19 studies.

    February 11, 2022
    General
    AVAC
  • 2022 is a critical year for the evolving role of PrEP, anti-retroviral drugs (ARVS) used to prevent HIV. If advocacy, global coordination, funding, and community-centered responses come together now, PrEP programs can be scaled, and these biomedical options can be translated into actual choices.

    February 7, 2022
    AVAC
  • In the first three weeks of January, AVAC hosted three important conversations for the year ahead. Global health leaders and stalwart advocates provide critical perspectives and compass points on the issues that will make and break advances in HIV prevention and global health equity this year.

    January 31, 2022
    AVAC

Pages